185 related articles for article (PubMed ID: 38437852)
21. The role of orexin in fatigue and sleep quality in patients with primary Sjögren's syndrome.
Sandikci SC; Gultuna S; Ozisler C; Aydin FN
Z Rheumatol; 2024 Feb; 83(Suppl 1):242-247. PubMed ID: 38108866
[TBL] [Abstract][Full Text] [Related]
22. Factors influencing the EULAR Sjögren's Syndrome Patient-Reported Index in primary Sjögren's syndrome.
Sandoval-Flores MG; Chan-Campos I; Hernández-Molina G
Clin Exp Rheumatol; 2021; 39 Suppl 133(6):153-158. PubMed ID: 34128801
[TBL] [Abstract][Full Text] [Related]
23. Responsiveness of disease activity indices ESSPRI and ESSDAI in patients with primary Sjögren's syndrome treated with rituximab.
Meiners PM; Arends S; Brouwer E; Spijkervet FK; Vissink A; Bootsma H
Ann Rheum Dis; 2012 Aug; 71(8):1297-302. PubMed ID: 22258489
[TBL] [Abstract][Full Text] [Related]
24. Disease phenotype and diagnostic delay in Saudi patients with primary Sjögren's syndrome: An exploratory cross-sectional study.
Omair MA; AlQahtani BS; AlHamad EH; Tashkandy YA; Othman NS; AlShahrani KA; Paramasivam MP; AlEnzi F; Halwani R; Daghestani MH
Saudi Med J; 2021 Apr; 42(4):405-410. PubMed ID: 33795496
[TBL] [Abstract][Full Text] [Related]
25. Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohort.
Gottenberg JE; Seror R; Miceli-Richard C; Benessiano J; Devauchelle-Pensec V; Dieude P; Dubost JJ; Fauchais AL; Goeb V; Hachulla E; Hatron PY; Larroche C; Le Guern V; Morel J; Perdriger A; Puéchal X; Rist S; Saraux A; Sene D; Sibilia J; Vittecoq O; Nocturne G; Ravaud P; Mariette X
PLoS One; 2013; 8(5):e59868. PubMed ID: 23717383
[TBL] [Abstract][Full Text] [Related]
26. Associations of cigarette smoking with disease phenotype and type I interferon expression in primary Sjögren's syndrome.
Olsson P; Bodewes ILA; Nilsson AM; Turesson C; Jacobsson LTH; Theander E; Versnel MA; Mandl T
Rheumatol Int; 2019 Sep; 39(9):1575-1584. PubMed ID: 31139950
[TBL] [Abstract][Full Text] [Related]
27. Outcome measures for primary Sjögren's syndrome.
Seror R; Bootsma H; Bowman SJ; Dörner T; Gottenberg JE; Mariette X; Ramos-Casals M; Ravaud P; Theander E; Tzioufas A; Vitali C
J Autoimmun; 2012 Aug; 39(1-2):97-102. PubMed ID: 22365784
[TBL] [Abstract][Full Text] [Related]
28. Advances in the understanding and treatment of systemic complications in Sjögren's syndrome.
Brito-Zerón P; Ramos-Casals M;
Curr Opin Rheumatol; 2014 Sep; 26(5):520-7. PubMed ID: 25050925
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of systemic activity of pediatric primary Sjögren's syndrome by EULAR Sjögren's syndrome disease activity index (ESSDAI).
Kobayashi I; Okura Y; Ueki M; Tozawa Y; Takezaki S; Yamada M; Ariga T
Mod Rheumatol; 2019 Jan; 29(1):130-133. PubMed ID: 29529894
[TBL] [Abstract][Full Text] [Related]
30. Do the EULAR Sjögren's syndrome outcome measures correlate with health status in primary Sjögren's syndrome?
Lendrem D; Mitchell S; McMeekin P; Gompels L; Hackett K; Bowman S; Price E; Pease CT; Emery P; Andrews J; Lanyon P; Hunter J; Gupta M; Bombardieri M; Sutcliffe N; Pitzalis C; McLaren J; Cooper A; Regan M; Giles I; Isenberg D; Saravanan V; Coady D; Dasgupta B; McHugh N; Young-Min S; Moots R; Gendi N; Akil M; Griffiths B; Ng WF;
Rheumatology (Oxford); 2015 Apr; 54(4):655-9. PubMed ID: 25240612
[TBL] [Abstract][Full Text] [Related]
31. Longitudinal analysis of symptom-based clustering in patients with primary Sjogren's syndrome: a prospective cohort study with a 5-year follow-up period.
Lee JJ; Park YJ; Park M; Yim HW; Park SH; Kwok SK
J Transl Med; 2021 Sep; 19(1):394. PubMed ID: 34538269
[TBL] [Abstract][Full Text] [Related]
32. Impact of sleep quality on clinical features of primary Sjögren's syndrome.
Chung SW; Hur J; Ha YJ; Kang EH; Hyon JY; Lee HJ; Song YW; Lee YJ
Korean J Intern Med; 2019 Sep; 34(5):1154-1164. PubMed ID: 29458245
[TBL] [Abstract][Full Text] [Related]
33. Concomitant fibromyalgia in primary Sjögren's syndrome in the French ASSESS cohort: comparison of the ACR 1990 and ACR 2016 criteria, FiRST questionnaire and physician's opinion.
Dubost JJ; Couderc M; Pereira B; Mariette X; Seror R; Gottenberg JE; Hachulla E; Le Guern V; Saraux A; Morel J; Salliot C; Tournadre A; Soubrier M
Clin Exp Rheumatol; 2021; 39 Suppl 133(6):140-145. PubMed ID: 34919043
[TBL] [Abstract][Full Text] [Related]
34. Serological lymphocytic activity and patient-reported outcomes in Sjögren's syndrome.
Jülich M; Kanne AM; Sehnert B; Budweiser S; Voll RE; Kollert F
Clin Rheumatol; 2018 Sep; 37(9):2361-2366. PubMed ID: 29858711
[TBL] [Abstract][Full Text] [Related]
35. Patient Acceptable Symptom State (PASS) in patients with primary Sjögren's syndrome in daily clinical practice.
de Wolff L; Vissink A; van Nimwegen JF; van Zuiden G; Mossel E; Olie L; Stel AJ; Delli K; Verstappen GM; Kroese FGM; Bootsma H; Arends S
Clin Exp Rheumatol; 2022 Dec; 40(12):2303-2309. PubMed ID: 36441658
[TBL] [Abstract][Full Text] [Related]
36. Utility of the EULAR Sjögren syndrome disease activity index in Japanese children: a retrospective multicenter cohort study.
Iwata N; Tomiita M; Kobayashi I; Inoue Y; Nonaka Y; Okamoto N; Umebayashi H; Hara R; Ito Y; Sato Y; Mori M
Pediatr Rheumatol Online J; 2020 Sep; 18(1):73. PubMed ID: 32943063
[TBL] [Abstract][Full Text] [Related]
37. EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI) and Other Patient-Reported Outcomes in the Assessment of Glandular Dysfunction in Primary Sjögren's Syndrome.
Ture HY; Kim NR; Nam EJ
Life (Basel); 2023 Sep; 13(10):. PubMed ID: 37895373
[TBL] [Abstract][Full Text] [Related]
38. Elevated levels of faecal calprotectin in primary Sjögren's syndrome is common and associated with concomitant organic gastrointestinal disease.
Andréasson K; Ohlsson B; Mandl T
Arthritis Res Ther; 2016 Jan; 18():9. PubMed ID: 26759247
[TBL] [Abstract][Full Text] [Related]
39. Clinical determinants of vaginal dryness in patients with primary Sjögren's syndrome.
Farenhorst CA; de Wolff L; Arends S; van Nimwegen JF; Kroese FGM; Verstappen GM; Bootsma H
Clin Exp Rheumatol; 2021; 39 Suppl 133(6):73-79. PubMed ID: 34665706
[TBL] [Abstract][Full Text] [Related]
40. Disease activity and damage in patients with primary Sjogren's syndrome: Prognostic value of salivary gland ultrasonography.
Milic V; Colic J; Cirkovic A; Stanojlovic S; Damjanov N
PLoS One; 2019; 14(12):e0226498. PubMed ID: 31891590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
